Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
AD     Remove this Ad

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹198 Cr₹154 Cr₹140 Cr₹114 Cr₹69 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹198 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr
Mar2021₹69 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr
66.71
Mar2021 ₹69 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹551.3 Cr -2.3% -0.7% 3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-2.3%

-0.7%

3.7%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses